Index -
P/E 29.66
EPS (ttm) 8.36
Insider Own 23.48%
Shs Outstand 31.02M
Perf Week -2.63%
Market Cap 7.58B
Forward P/E 25.46
EPS next Y 9.74
Insider Trans -14.11%
Shs Float 23.39M
Perf Month -5.22%
Income 268.48M
PEG 2.09
EPS next Q 2.04
Inst Own 80.07%
Short Float / Ratio 4.26% / 3.44
Perf Quarter 8.25%
Sales 1.67B
P/S 4.53
EPS this Y 15.26%
Inst Trans -1.68%
Short Interest 1.00M
Perf Half Y 36.62%
Book/sh 12.80
P/B 19.38
EPS next Y 16.08%
ROA 19.72%
Target Price 267.00
Perf Year 67.90%
Cash/sh 1.28
P/C 193.64
EPS next 5Y 14.21%
ROE 79.63%
52W Range 146.05 - 282.73
Perf YTD 16.76%
Dividend -
P/FCF 19.39
EPS past 5Y 49.35%
ROI 50.61%
52W High -12.28%
Beta 1.39
Dividend % -
Quick Ratio 0.44
Sales past 5Y 28.49%
Gross Margin 27.80%
52W Low 69.80%
ATR 7.06
Employees 5200
Current Ratio 0.44
Sales Q/Q 31.22%
Oper. Margin 19.06%
RSI (14) 40.33
Volatility 3.25% 2.54%
Optionable Yes
Debt/Eq 0.55
EPS Q/Q 32.02%
Profit Margin 16.05%
Rel Volume 0.90
Prev Close 242.15
Shortable Yes
LT Debt/Eq 0.36
Earnings Jul 24 AMC
Payout 0.00%
Avg Volume 289.29K
Price 248.00
Recom 2.50
SMA20 -6.62%
SMA50 -4.45%
SMA200 11.64%
Volume 259,266
Change 2.42%
Date
Action
Analyst
Rating Change
Price Target Change
May-08-23 Upgrade
Guggenheim
Neutral → Buy
$252
Oct-27-22 Upgrade
UBS
Sell → Neutral
$142 → $238
Sep-07-22 Initiated
UBS
Sell
$142
May-24-22 Initiated
Guggenheim
Neutral
Aug-05-21 Resumed
Credit Suisse
Outperform
$205
Oct-02-20 Upgrade
Truist
Hold → Buy
$124 → $135
Jun-08-20 Upgrade
Robert W. Baird
Underperform → Neutral
$83
May-13-20 Downgrade
Wolfe Research
Outperform → Peer Perform
Apr-30-20 Upgrade
SunTrust
Sell → Hold
$85
Apr-20-20 Downgrade
Robert W. Baird
Neutral → Underperform
$77
Mar-17-20 Downgrade
SunTrust
Hold → Sell
Jan-27-20 Downgrade
SunTrust
Buy → Hold
$85 → $87
Oct-31-18 Upgrade
SunTrust
Hold → Buy
Sep-17-18 Initiated
SunTrust
Hold
$63
Jul-31-18 Upgrade
William Blair
Mkt Perform → Outperform
Nov-01-17 Downgrade
William Blair
Outperform → Mkt Perform
Sep-29-17 Initiated
Raymond James
Mkt Perform
Jul-10-17 Downgrade
KeyBanc Capital Mkts
Overweight → Sector Weight
Show Previous Ratings
Sep-26-23 04:05PM
Sep-21-23 06:40PM
(Morningstar Research) -5.45%
Sep-19-23 12:36PM
Sep-01-23 09:15AM
Aug-30-23 06:54AM
07:47AM
Loading…
Aug-29-23 07:47AM
Aug-23-23 08:30AM
Jul-26-23 09:54AM
Jul-25-23 10:55PM
(Thomson Reuters StreetEvents)
06:51PM
Jul-24-23 04:36PM
04:15PM
Jul-05-23 04:05PM
Jun-21-23 08:00PM
Jun-16-23 05:00AM
(American City Business Journals)
02:16PM
Loading…
May-18-23 02:16PM
May-06-23 08:00AM
May-04-23 11:34AM
May-02-23 12:10AM
Apr-29-23 07:00AM
Apr-26-23 08:00PM
Apr-25-23 11:07PM
(Thomson Reuters StreetEvents) +11.22%
04:01PM
(Investor's Business Daily)
Apr-24-23 04:46PM
04:15PM
Apr-20-23 10:07AM
Mar-28-23 04:05PM
Mar-22-23 01:41PM
Mar-21-23 06:42AM
Mar-01-23 06:34AM
08:04AM
Loading…
Feb-26-23 08:04AM
Feb-15-23 03:36PM
05:27AM
Feb-13-23 04:56PM
Feb-10-23 12:02AM
Jan-25-23 03:54AM
(American City Business Journals)
Jan-20-23 08:20AM
(Investor's Business Daily)
Jan-19-23 09:57PM
(Investor's Business Daily)
06:10PM
(Investor's Business Daily)
Jan-14-23 09:47AM
08:23AM
Jan-10-23 04:36PM
(Investor's Business Daily) +5.91%
Jan-04-23 04:05PM
Dec-28-22 08:00AM
(Investor's Business Daily)
Dec-23-22 06:32AM
(American City Business Journals)
Dec-16-22 04:19PM
(Investor's Business Daily)
Dec-15-22 11:32AM
Dec-09-22 10:53AM
09:43AM
Dec-06-22 12:53PM
Dec-05-22 11:41AM
08:46AM
Dec-02-22 09:12AM
Nov-25-22 09:37AM
08:15AM
(Investor's Business Daily)
Nov-24-22 03:04PM
01:10PM
(Investor's Business Daily)
Nov-22-22 03:17PM
09:08AM
Nov-21-22 12:45PM
Nov-15-22 10:00AM
Nov-14-22 10:02AM
Nov-11-22 10:26AM
09:49AM
06:35AM
Nov-10-22 11:16AM
10:43AM
10:31AM
08:35AM
Nov-09-22 10:38AM
09:59AM
09:52AM
08:39AM
Nov-08-22 10:39AM
10:32AM
10:00AM
09:24AM
06:27AM
Nov-07-22 10:16AM
09:58AM
Nov-04-22 12:10PM
11:48AM
10:47AM
10:05AM
09:50AM
Nov-03-22 12:51PM
11:59AM
11:28AM
11:25AM
11:17AM
11:04AM
11:02AM
10:44AM
Nov-02-22 11:37AM
11:34AM
11:13AM
10:30AM
09:14AM
Nov-01-22 01:11PM
12:15PM
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Troendle August J. CEO Sep 21 Sale 244.27 61,655 15,060,467 5,914,947 Sep 21 09:41 PM Medpace Investors, LLC 10% Owner Sep 21 Sale 244.27 61,655 15,060,467 5,914,947 Sep 21 09:40 PM Medpace Investors, LLC 10% Owner Sep 20 Sale 255.48 65,653 16,773,028 5,976,602 Sep 21 09:40 PM Troendle August J. CEO Sep 20 Sale 255.48 65,653 16,773,028 5,976,602 Sep 21 09:41 PM Troendle August J. CEO Sep 19 Sale 259.66 137,379 35,671,831 6,042,255 Sep 20 04:15 PM Medpace Investors, LLC 10% Owner Sep 19 Sale 259.66 137,379 35,671,831 6,042,255 Sep 20 04:16 PM Medpace Investors, LLC 10% Owner Sep 18 Sale 274.76 53,385 14,668,063 6,179,634 Sep 20 04:16 PM Troendle August J. CEO Sep 18 Sale 274.76 53,385 14,668,063 6,179,634 Sep 20 04:15 PM Kraft Robert O. Director Aug 14 Option Exercise 26.44 13,782 364,396 13,970 Aug 16 04:15 PM Kraft Robert O. Director Aug 14 Sale 265.67 13,782 3,661,464 188 Aug 16 04:15 PM Brady Kevin M. CFO & Treasurer Jul 31 Option Exercise 90.65 10,000 906,500 13,000 Aug 02 04:15 PM Brady Kevin M. CFO & Treasurer Jul 31 Sale 255.00 7,000 1,785,000 6,000 Aug 02 04:15 PM EWALD STEPHEN P General Counsel & Corp. Secy. Jul 27 Option Exercise 107.93 21,850 2,358,270 36,704 Jul 31 04:41 PM EWALD STEPHEN P General Counsel & Corp. Secy. Jul 27 Sale 254.39 21,850 5,558,422 14,854 Jul 31 04:41 PM Carley Brian T Director Jun 15 Option Exercise 23.00 7,400 170,200 7,504 Jun 20 04:15 PM Troendle August J. CEO Jun 08 Sale 220.85 49,347 10,898,285 6,233,019 Jun 12 04:32 PM Medpace Investors, LLC 10% Owner Jun 08 Sale 220.85 49,347 10,898,285 6,233,019 Jun 12 04:30 PM Troendle August J. CEO Jun 07 Sale 223.05 110,324 24,607,768 6,282,366 Jun 08 04:16 PM Medpace Investors, LLC 10% Owner Jun 07 Sale 223.05 110,324 24,607,768 6,282,366 Jun 08 04:15 PM Medpace Investors, LLC 10% Owner Jun 06 Sale 220.46 58,681 12,936,813 6,392,690 Jun 08 04:15 PM Troendle August J. CEO Jun 06 Sale 220.46 58,681 12,936,813 6,392,690 Jun 08 04:16 PM Troendle August J. CEO Apr 25 Sale 221.83 31,648 7,020,476 6,451,371 Apr 27 04:24 PM Medpace Investors, LLC 10% Owner Apr 25 Sale 221.83 31,648 7,020,476 6,451,371 Apr 27 04:23 PM Brady Kevin M. CFO & Treasurer Nov 16 Sale 227.09 344 78,119 3,000 Nov 17 04:21 PM GEIGER JESSE J President Nov 15 Option Exercise 28.32 7,000 198,240 13,382 Nov 17 04:20 PM GEIGER JESSE J President Nov 15 Sale 230.00 7,000 1,610,000 6,382 Nov 17 04:20 PM Brady Kevin M. CFO & Treasurer Nov 15 Sale 229.30 1,656 379,721 3,344 Nov 17 04:21 PM Kraft Robert O. Director Nov 01 Option Exercise 23.00 9,630 221,490 9,630 Nov 03 04:16 PM Kraft Robert O. Director Nov 01 Sale 221.42 9,630 2,132,275 0 Nov 03 04:16 PM EWALD STEPHEN P General Counsel & Corp. Secy. Oct 27 Option Exercise 32.05 6,500 208,325 21,354 Oct 31 04:38 PM EWALD STEPHEN P General Counsel & Corp. Secy. Oct 27 Sale 220.53 6,500 1,433,445 14,854 Oct 31 04:38 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite